Valente Manuela 4
4 · SOPHiA GENETICS SA · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells Shares
What Happened
Manuela Valente, Chief People Officer of SOPHiA GENETICS (SOPH), sold 3,824 shares in an open-market transaction on April 8, 2026. The weighted-average sale price was $4.85 per share (range $4.78–$4.94), for total proceeds of approximately $18,543. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations related to RSU vesting.
Key Details
- Transaction date: April 8, 2026; Form filed April 10, 2026 (appears timely).
- Shares sold: 3,824; weighted-average price reported: $4.85; price range: $4.78–$4.94.
- Total proceeds: ~$18,543.
- Reason/footnotes: Sales effected to satisfy tax withholding for restricted stock units that vested on April 2 and 3, 2026; executed pursuant to a pre-established Rule 10b5-1 trading plan (non-discretionary).
- Footnote also notes the filer can provide breakdown of how many shares sold at each price within the stated range upon written request.
- Shares owned after the transaction: not reported in this filing.
Context
These transactions were tax-withholding related and part of a pre-established 10b5-1 plan, which insiders commonly use to sell shares tied to compensation events; such sales are generally considered routine and do not necessarily indicate a change in the insider’s view of the company. Purchases (not present here) tend to carry more informational weight for investors.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-04-08$4.85/sh−3,824$18,543→ 215,451 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.